Back to Search
Start Over
Supplementary Expression Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Expression Data. Individual expression values for all 211 genes interrogated in the tumor tissue of 55 patients.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....4719fdaa52cff5b2368e357113fb40cf
- Full Text :
- https://doi.org/10.1158/1078-0432.22461254